Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial
Abstract Background Idiopathic pulmonary fibrosis (IPF) is characterized by a poor prognosis, with a progressive decline in lung function and considerable variability in the disease’s natural history. Besides lung transplantation (LTx), the only available treatments are anti-fibrosing drugs, which h...
Guardado en:
Autores principales: | Gian Marco Manzetti, Karishma Hosein, Matthew J. Cecchini, Keith Kwan, Mohamed Abdelrazek, Maurizio Zompatori, Paola Rogliani, Marco Mura |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d941364ce766476cb72b8b4b0e4d70b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Supervivencia de pacientes con fibrosis pulmonar idiopática diagnosticados por biopsia quirúrgica de pulmón: experiencia del Instituto Nacional del Tórax
por: Salinas,Mauricio, et al.
Publicado: (2014) -
Impact of high-flow oxygen therapy during exercise in idiopathic pulmonary fibrosis: a pilot crossover clinical trial
por: Diana Badenes-Bonet, et al.
Publicado: (2021) -
Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis
por: Henrik Jessen, et al.
Publicado: (2021) -
CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis
por: Yupeng Li, et al.
Publicado: (2021) -
Interstitial lung abnormalities – current knowledge and future directions
por: Gisli Thor Axelsson, et al.
Publicado: (2021)